These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22786830)

  • 41. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles.
    Fugh-Berman A; McDonald CP; Bell AM; Bethards EC; Scialli AR
    PLoS Med; 2011 Mar; 8(3):e1000425. PubMed ID: 21423581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Menopausal hormone therapy for the primary prevention of chronic conditions.
    Buckler A; Voss J
    Am Fam Physician; 2013 Mar; 87(6):437-8. PubMed ID: 23547577
    [No Abstract]   [Full Text] [Related]  

  • 45. WHI risks: any relevance to menopause management?
    Burger HG
    Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hormone therapy: evolving concepts.
    Hendrix SL
    Curr Opin Rheumatol; 2003 Jul; 15(4):464-8. PubMed ID: 12819476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.
    Velentzis LS; Salagame U; Canfell K
    BMC Health Serv Res; 2017 May; 17(1):326. PubMed ID: 28476121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Behavioral interventions and counseling to prevent child abuse and neglect: a systematic review to update the US Preventive services task force recommendation.
    Selph SS; Bougatsos C; Blazina I; Nelson HD
    Ann Intern Med; 2013 Feb; 158(3):179-90. PubMed ID: 23338775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.
    Miller J; Chan BK; Nelson HD
    Ann Intern Med; 2002 May; 136(9):680-90. PubMed ID: 11992304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening women for intimate partner violence: a systematic review to update the U.S. Preventive Services Task Force recommendation.
    Nelson HD; Bougatsos C; Blazina I
    Ann Intern Med; 2012 Jun; 156(11):796-808, W-279, W-280, W-281, W-282. PubMed ID: 22565034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical trials in menopause.
    Marko KI; Simon JA
    Menopause; 2018 Feb; 25(2):217-230. PubMed ID: 28953214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Nov; 137(10):834-9. PubMed ID: 12435221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An update on menopausal hormone replacement therapy in women and cardiovascular disease.
    Valdiviezo C; Lawson S; Ouyang P
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):148-55. PubMed ID: 23422240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Women's health. The vanishing promises of hormone replacement.
    Enserink M
    Science; 2002 Jul; 297(5580):325-6. PubMed ID: 12130763
    [No Abstract]   [Full Text] [Related]  

  • 58. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Fu R; Cantor A; Pappas M; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):244-55. PubMed ID: 26756588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.